BCL2 and breast cancer: Additionally, miR-221 [122] and miR-944 [123] were found to prevent BC from undergoing apoptosis and instigate cisplatin resistance through direct repression of Bcl-2-like protein 11 (Bim) and BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (Bnip-3), respectively.